Davis, Mitchell S.
Spencer, Riley K.
Johnson, Chandler E.
Elhage, Kareem G.
Jin, Joy Q.
Hakimi, Marwa
Bhutani, Tina
Liao, Wilson http://orcid.org/0000-0001-7883-6439
Article History
Received: 6 October 2023
Accepted: 13 November 2023
First Online: 3 December 2023
Declarations
:
: Tina Bhutani is a principal investigator for trials sponsored by Abbvie, Castle, CorEvitas, Dermavant, Galderma, Mindera, and Pfizer. She has served as an advisor for Abbvie, Arcutis, Boehringer-Ingelheim, Bristol Myers Squibb, Janssen, Leo, Lilly, Novartis, Pfizer, Sun, and UCB. Wilson Liao has received research grant funding from Abbvie, Amgen, Janssen, Leo, Novartis, Pfizer, Regeneron, and TRex Bio. Mitchell Davis, Riley Spencer, Kareem Elhage, Chandler Johnson, and Marwa Hakimi declare that they have no competing interests. Joy Jin has received research grant funding from the National Psoriasis Foundation and institutional funding from the University of California, San Francisco. Tina Bhutani has received research grant funding from Novartis and Regeneron. Wilson Liao has received research grant funding from Abbvie, Amgen, Janssen, Leo, Novartis, Pfizer, Regeneron, and TRex Bio. No funding sources are relevant to this manuscript Mitchell Davis, Riley Spencer, Kareem Elhage, Chandler Johnson, and Marwa Hakimi have nothing to disclose.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.